Ngā hua rapu - Erin Brophy

  • E whakaatu ana i te 1 - 2 hua o te 2
Whakamahine hua
  1. 1
    Discovery of a Selective Phosphoinositide-3-Kinase (PI3K)-γ Inhibitor (IPI-549) as an Immuno-Oncology Clinical Candidate

    Discovery of a Selective Phosphoinositide-3-Kinase (PI3K)-γ Inhibitor (IPI-549) as an Immuno-Oncology Clinical Candidate mā Catherine A. Evans, Tao Liu, André Lescarbeau, Somarajan Nair, Louis Grenier, Johan A. Pradeilles, Quentin Glenadel, Thomas T. Tibbitts, Ann Rowley, Jonathan P. DiNitto, Erin Brophy, Erin O’Hearn, Janid A. Ali, David G. Winkler, Stanley I. Goldstein, Patrick J. O’Hearn, Christian M. Martin, Jennifer Hoyt, John R. Soglia, Culver Cheung, Melissa Pink, Jennifer Proctor, Vito J. Palombella, Martin Tremblay, Alfredo Castro

    I whakaputaina 2016
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    PI3K-δ and PI3K-γ Inhibition by IPI-145 Abrogates Immune Responses and Suppresses Activity in Autoimmune and Inflammatory Disease Models

    PI3K-δ and PI3K-γ Inhibition by IPI-145 Abrogates Immune Responses and Suppresses Activity in Autoimmune and Inflammatory Disease Models mā David G. Winkler, L. Kerrie, Jonathan P. DiNitto, Janid A. Ali, Kerry White, Erin Brophy, Melissa Pink, Jennifer Proctor, Jennifer Lussier, Christian M. Martin, Jennifer Hoyt, Bonnie Tillotson, Erin L. Murphy, Alice R. Lim, Brian D. Thomas, John R. MacDougall, Pingda Ren, Yi Liu, Lian‐Sheng Li, Katti Jessen, Christian Fritz, Joi Dunbar, James R. Porter, Christian Rommel, Vito J. Palombella, Paul S. Changelian, Jeffery L. Kutok

    I whakaputaina 2013
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: